A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Cilengitide (Primary)
- Indications Cancer
- Focus Adverse reactions
- 22 Sep 2009 Actual end date (Aug 2001), actual number of patients (40) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2005 New trial record.